Amedeo Smart

Free Medical Literature Service


 

Amedeo

Influenza

  Free Subscription

Articles published in
Cell
    September 2021
  1. ZIEGLER CGK, Miao VN, Owings AH, Navia AW, et al
    Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19.
    Cell. 2021;184:4713-4733.
    >> Share

    August 2021
  2. KARLSSON EA, Duong V
    The continuing search for the origins of SARS-CoV-2.
    Cell. 2021;184:4373-4374.
    >> Share

  3. KANG L, He G, Sharp AK, Wang X, et al
    A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation.
    Cell. 2021;184:4392-4400.
    >> Share

  4. NATHAN A, Rossin EJ, Kaseke C, Park RJ, et al
    Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.
    Cell. 2021;184:4401-4413.
    >> Share

  5. ZHOU H, Ji J, Chen X, Bi Y, et al
    Identification of novel bat coronaviruses sheds light on the evolutionary origins of SARS-CoV-2 and related viruses.
    Cell. 2021;184:4380-4391.
    >> Share

  6. LIU C, Ginn HM, Dejnirattisai W, Supasa P, et al
    Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.
    Cell. 2021;184:4220-4236.
    >> Share

  7. LI D, Edwards RJ, Manne K, Martinez DR, et al
    In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies.
    Cell. 2021;184:4203-4219.
    >> Share

    July 2021
  8. RESCIGNO M
    Unraveling the long-term effect of influenza vaccines.
    Cell. 2021;184:3845-3847.
    >> Share

  9. WEINGARTEN-GABBAY S, Klaeger S, Sarkizova S, Pearlman LR, et al
    Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.
    Cell. 2021;184:3962-3980.
    >> Share

  10. COPIN R, Baum A, Wloga E, Pascal KE, et al
    The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.
    Cell. 2021;184:3949-3961.
    >> Share

    June 2021
  11. YAN L, Yang Y, Li M, Zhang Y, et al
    Coupling of N7-methyltransferase and 3'-5' exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading.
    Cell. 2021;184:3474-3485.
    >> Share

  12. LIU K, Pan X, Li L, Yu F, et al
    Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species.
    Cell. 2021;184:3438-3451.
    >> Share

  13. LIU Y, Soh WT, Kishikawa JI, Hirose M, et al
    An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies.
    Cell. 2021;184:3452-3466.
    >> Share

  14. HE X, Chandrashekar A, Zahn R, Wegmann F, et al
    Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques.
    Cell. 2021;184:3467-3473.
    >> Share

  15. HAO Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, et al
    Integrated analysis of multimodal single-cell data.
    Cell. 2021;184:3573-3587.
    >> Share

  16. DENG X, Garcia-Knight MA, Khalid MM, Servellita V, et al
    Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant.
    Cell. 2021;184:3426-3437.
    >> Share

  17. WIMMERS F, Donato M, Kuo A, Ashuach T, et al
    The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination.
    Cell. 2021 Jun 22. pii: S0092-8674(21)00692-9. doi: 10.1016/j.cell.2021.
    >> Share

  18. CORTI D, Purcell LA, Snell G, Veesler D, et al
    Tackling COVID-19 with neutralizing monoclonal antibodies.
    Cell. 2021;184:3086-3108.
    >> Share

  19. SCHEID JF, Barnes CO, Eraslan B, Hudak A, et al
    B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV.
    Cell. 2021;184:3205-3221.
    >> Share

  20. ASARNOW D, Wang B, Lee WH, Hu Y, et al
    Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia.
    Cell. 2021;184:3192-3204.
    >> Share

    May 2021
  21. BAUMER Y, Powell-Wiley TM
    Interdisciplinary approaches are fundamental to decode the biology of adversity.
    Cell. 2021;184:2797-2801.
    >> Share

  22. GARRETT ME, Galloway J, Chu HY, Itell HL, et al
    High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies.
    Cell. 2021;184:2927-2938.
    >> Share

  23. DEJNIRATTISAI W, Zhou D, Supasa P, Liu C, et al
    Antibody evasion by the P.1 strain of SARS-CoV-2.
    Cell. 2021;184:2939-2954.
    >> Share

  24. WILLIAMS WB, Meyerhoff RR, Edwards RJ, Li H, et al
    Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies.
    Cell. 2021 May 18. pii: S0092-8674(21)00577-8. doi: 10.1016/j.cell.2021.
    >> Share

  25. ALPERT T, Brito AF, Lasek-Nesselquist E, Rothman J, et al
    Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States.
    Cell. 2021;184:2595-2604.
    >> Share

  26. WASHINGTON NL, Gangavarapu K, Zeller M, Bolze A, et al
    Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States.
    Cell. 2021;184:2587-2594.
    >> Share

  27. HO JSY, Mok BW, Campisi L, Jordan T, et al
    TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation.
    Cell. 2021;184:2618-2632.
    >> Share

  28. CLARK SA, Clark LE, Pan J, Coscia A, et al
    SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms.
    Cell. 2021;184:2605-2617.
    >> Share

    April 2021
  29. LEBLANC EV, Colpitts CC
    SARS-CoV-2 RNA: Exclusive friends and common foes.
    Cell. 2021;184:2276-2278.
    >> Share

  30. BOEHM JS
    The power of parent scientists.
    Cell. 2021;184:2263-2270.
    >> Share

  31. HOFFMANN M, Arora P, Gross R, Seidel A, et al
    SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.
    Cell. 2021;184:2384-2393.
    >> Share

  32. SURYADEVARA N, Shrihari S, Gilchuk P, VanBlargan LA, et al
    Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein.
    Cell. 2021;184:2316-2331.
    >> Share

  33. FABIUS JM, Krogan NJ
    Creating collaboration by breaking down scientific barriers.
    Cell. 2021;184:2271-2275.
    >> Share

  34. MCCALLUM M, De Marco A, Lempp FA, Tortorici MA, et al
    N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.
    Cell. 2021;184:2332-2347.
    >> Share

  35. GARCIA-BELTRAN WF, Lam EC, St Denis K, Nitido AD, et al
    Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.
    Cell. 2021;184:2372-2383.
    >> Share

  36. FLYNN RA, Belk JA, Qi Y, Yasumoto Y, et al
    Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions.
    Cell. 2021;184:2394-2411.
    >> Share

  37. ZHOU D, Dejnirattisai W, Supasa P, Liu C, et al
    Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.
    Cell. 2021;184:2348-2361.
    >> Share


  38. The origins of viral infection sleuth.
    Cell. 2021;184:1960-1961.
    >> Share

  39. SCHNEIDER JL, Rowe JH, Garcia-de-Alba C, Kim CF, et al
    The aging lung: Physiology, disease, and immunity.
    Cell. 2021;184:1990-2019.
    >> Share

  40. MILLS RJ, Humphrey SJ, Fortuna PRJ, Lor M, et al
    BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection.
    Cell. 2021;184:2167-2182.
    >> Share

  41. DEJNIRATTISAI W, Zhou D, Ginn HM, Duyvesteyn HME, et al
    The antigenic anatomy of SARS-CoV-2 receptor binding domain.
    Cell. 2021;184:2183-2200.
    >> Share

  42. SUPASA P, Zhou D, Dejnirattisai W, Liu C, et al
    Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.
    Cell. 2021;184:2201-2211.
    >> Share

  43. YEUNG ML, Teng JLL, Jia L, Zhang C, et al
    Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system.
    Cell. 2021;184:2212-2228.
    >> Share

  44. ZHANG X, Liu Y, Liu J, Bailey AL, et al
    A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence.
    Cell. 2021;184:2229-2238.
    >> Share

  45. SCHULTZE JL, Aschenbrenner AC
    COVID-19 and the human innate immune system.
    Cell. 2021;184:1671-1692.
    >> Share

  46. YU B, Qi Y, Li R, Shi Q, et al
    B cell-specific XIST complex enforces X-inactivation and restrains atypical B cells.
    Cell. 2021;184:1790-1803.
    >> Share

  47. LIU C, Martins AJ, Lau WW, Rachmaninoff N, et al
    Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19.
    Cell. 2021;184:1836-1857.
    >> Share

  48. WINKLER ES, Gilchuk P, Yu J, Bailey AL, et al
    Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection.
    Cell. 2021;184:1804-1820.
    >> Share

  49. ANDREANO E, Nicastri E, Paciello I, Pileri P, et al
    Extremely potent human monoclonal antibodies from COVID-19 convalescent patients.
    Cell. 2021;184:1821-1835.
    >> Share

  50. REN X, Wen W, Fan X, Hou W, et al
    COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.
    Cell. 2021;184:1895-1913.
    >> Share

  51. SUN L, Li P, Ju X, Rao J, et al
    In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs.
    Cell. 2021;184:1865-1883.
    >> Share

  52. ANDERSON EM, Goodwin EC, Verma A, Arevalo CP, et al
    Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection.
    Cell. 2021;184:1858-1864.
    >> Share

    March 2021
  53. GEBRE MS, Brito LA, Tostanoski LH, Edwards DK, et al
    Novel approaches for vaccine development.
    Cell. 2021;184:1589-1603.
    >> Share

  54. SANDRONE S, Scott G, Anderson WJ, Musunuru K, et al
    Active learning-based STEM education for in-person and online learning.
    Cell. 2021;184:1409-1414.
    >> Share


  55. Scientific misinformation: A perfect storm, missteps, and moving forward.
    Cell. 2021;184:1402-1406.
    >> Share

  56. TOPOL EJ
    Messenger RNA vaccines against SARS-CoV-2.
    Cell. 2021;184:1401.
    >> Share

  57. PILLON NJ, Loos RJF, Marshall SM, Zierath JR, et al
    Metabolic consequences of obesity and type 2 diabetes: Balancing genes and environment for personalized care.
    Cell. 2021;184:1530-1544.
    >> Share

  58. MANN ME, Hall LJ, Dulvy NK
    Scientific impact in a changing world.
    Cell. 2021;184:1407-1408.
    >> Share

  59. THOMSON EC, Rosen LE, Shepherd JG, Spreafico R, et al
    Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity.
    Cell. 2021;184:1171-1187.
    >> Share

  60. GRUBAUGH ND, Hodcroft EB, Fauver JR, Phelan AL, et al
    Public health actions to control new SARS-CoV-2 variants.
    Cell. 2021;184:1127-1132.
    >> Share

  61. BROUWER PJM, Brinkkemper M, Maisonnasse P, Dereuddre-Bosquet N, et al
    Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection.
    Cell. 2021;184:1188-1200.
    >> Share

  62. SOKAL A, Chappert P, Barba-Spaeth G, Roeser A, et al
    Maturation and persistence of the anti-SARS-CoV-2 memory B cell response.
    Cell. 2021;184:1201-1213.
    >> Share

    February 2021
  63. LI Q, Nie J, Wu J, Zhang L, et al
    SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape.
    Cell. 2021 Feb 23. pii: S0092-8674(21)00231-2. doi: 10.1016/j.cell.2021.
    >> Share

  64. SETTE A, Crotty S
    Adaptive immunity to SARS-CoV-2 and COVID-19.
    Cell. 2021;184:861-880.
    >> Share

  65. NIE X, Qian L, Sun R, Huang B, et al
    Multi-organ proteomic landscape of COVID-19 autopsies.
    Cell. 2021;184:775-791.
    >> Share

  66. ATYEO C, Pullen KM, Bordt EA, Fischinger S, et al
    Compromised SARS-CoV-2-specific placental antibody transfer.
    Cell. 2021;184:628-642.
    >> Share

    January 2021
  67. GARCIA-BELTRAN WF, Lam EC, Astudillo MG, Yang D, et al
    COVID-19-neutralizing antibodies predict disease severity and survival.
    Cell. 2021;184:476-488.
    >> Share

  68. HOANG TN, Pino M, Boddapati AK, Viox EG, et al
    Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques.
    Cell. 2021;184:460-475.
    >> Share


  69. What happens next.
    Cell. 2021;184:291-292.
    >> Share

  70. HOFFMANN HH, Schneider WM, Rozen-Gagnon K, Miles LA, et al
    TMEM41B Is a Pan-flavivirus Host Factor.
    Cell. 2021;184:133-148.
    >> Share

  71. WANG R, Simoneau CR, Kulsuptrakul J, Bouhaddou M, et al
    Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses.
    Cell. 2021;184:106-119.
    >> Share

  72. RODDA LB, Netland J, Shehata L, Pruner KB, et al
    Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19.
    Cell. 2021;184:169-183.
    >> Share

  73. KARKI R, Sharma BR, Tuladhar S, Williams EP, et al
    Synergism of TNF-alpha and IFN-gamma Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes.
    Cell. 2021;184:149-168.
    >> Share

  74. VOLZ E, Hill V, McCrone JT, Price A, et al
    Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity.
    Cell. 2021;184:64-75.
    >> Share

  75. DANILOSKI Z, Jordan TX, Wessels HH, Hoagland DA, et al
    Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells.
    Cell. 2021;184:92-105.
    >> Share

  76. WEI J, Alfajaro MM, DeWeirdt PC, Hanna RE, et al
    Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection.
    Cell. 2021;184:76-91.
    >> Share

    December 2020
  77. AVANZATO VA, Matson MJ, Seifert SN, Pryce R, et al
    Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer.
    Cell. 2020;183:1901-1912.
    >> Share

  78. ZOHAR T, Loos C, Fischinger S, Atyeo C, et al
    Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality.
    Cell. 2020;183:1508-1519.
    >> Share

  79. SU Y, Chen D, Yuan D, Lausted C, et al
    Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.
    Cell. 2020;183:1479-1495.
    >> Share

  80. CHEN Y, Zuiani A, Fischinger S, Mullur J, et al
    Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production.
    Cell. 2020;183:1496-1507.
    >> Share

  81. GHOSH S, Dellibovi-Ragheb TA, Kerviel A, Pak E, et al
    beta-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway.
    Cell. 2020;183:1520-1535.
    >> Share

    November 2020
  82. WALLS AC, Fiala B, Schafer A, Wrenn S, et al
    Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2.
    Cell. 2020;183:1367-1382.
    >> Share

  83. MECKIFF BJ, Ramirez-Suastegui C, Fajardo V, Chee SJ, et al
    Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4(+) T Cells in COVID-19.
    Cell. 2020;183:1340-1353.
    >> Share

  84. BANERJEE AK, Blanco MR, Bruce EA, Honson DD, et al
    SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses.
    Cell. 2020;183:1325-1339.
    >> Share

  85. AID M, Busman-Sahay K, Vidal SJ, Maliga Z, et al
    Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques.
    Cell. 2020;183:1354-1366.
    >> Share

  86. KREYE J, Reincke SM, Kornau HC, Sanchez-Sendin E, et al
    A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model.
    Cell. 2020;183:1058-1069.
    >> Share

  87. LEIST SR, Dinnon KH 3rd, Schafer A, Tse LV, et al
    A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice.
    Cell. 2020;183:1070-1085.
    >> Share

  88. RYDYZNSKI MODERBACHER C, Ramirez SI, Dan JM, Grifoni A, et al
    Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.
    Cell. 2020;183:996-1012.
    >> Share

  89. PICCOLI L, Park YJ, Tortorici MA, Czudnochowski N, et al
    Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.
    Cell. 2020;183:1024-1042.
    >> Share

  90. GRUBER CN, Patel RS, Trachtman R, Lepow L, et al
    Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C).
    Cell. 2020;183:982-995.
    >> Share

  91. CLAUSEN TM, Sandoval DR, Spliid CB, Pihl J, et al
    SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.
    Cell. 2020;183:1043-1057.
    >> Share

  92. CONSIGLIO CR, Cotugno N, Sardh F, Pou C, et al
    The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19.
    Cell. 2020;183:968-981.
    >> Share

    October 2020
  93. YURKOVETSKIY L, Wang X, Pascal KE, Tomkins-Tinch C, et al
    Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant.
    Cell. 2020;183:739-751.
    >> Share

  94. MUKHERJEE S
    Before Virus, After Virus: A Reckoning.
    Cell. 2020;183:308-314.
    >> Share

  95. IWASAKI A, Omer SB
    Why and How Vaccines Work.
    Cell. 2020;183:290-295.
    >> Share

  96. GOLDSTEIN JL
    The Spanish 1918 Flu and the COVID-19 Disease: The Art of Remembering and Foreshadowing Pandemics.
    Cell. 2020;183:285-289.
    >> Share

  97. LI W, Schafer A, Kulkarni SS, Liu X, et al
    High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal Models.
    Cell. 2020;183:429-441.
    >> Share

  98. SEKINE T, Perez-Potti A, Rivera-Ballesteros O, Stralin K, et al
    Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.
    Cell. 2020;183:158-168.
    >> Share

  99. AU L, Boos LA, Swerdlow A, Byrne F, et al
    Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study.
    Cell. 2020;183:4-10.
    >> Share

  100. CANETE PF, Vinuesa CG
    COVID-19 Makes B Cells Forget, but T Cells Remember.
    Cell. 2020;183:13-15.
    >> Share

  101. HASSAN AO, Kafai NM, Dmitriev IP, Fox JM, et al
    A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.
    Cell. 2020;183:169-184.
    >> Share

  102. IADECOLA C, Anrather J, Kamel H
    Effects of COVID-19 on the Nervous System.
    Cell. 2020;183:16-27.
    >> Share

  103. KANEKO N, Kuo HH, Boucau J, Farmer JR, et al
    Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19.
    Cell. 2020;183:143-157.
    >> Share

    September 2020
  104. SILVIN A, Chapuis N, Dunsmore G, Goubet AG, et al
    Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19.
    Cell. 2020;182:1401-1418.
    >> Share

  105. COLUBRI A, Kemball M, Sani K, Boehm C, et al
    Preventing Outbreaks through Interactive, Experiential Real-Life Simulations.
    Cell. 2020;182:1366-1371.
    >> Share

  106. SCHULTE-SCHREPPING J, Reusch N, Paclik D, Bassler K, et al
    Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.
    Cell. 2020;182:1419-1440.
    >> Share

  107. DU S, Cao Y, Zhu Q, Yu P, et al
    Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy.
    Cell. 2020 Sep 14. pii: S0092-8674(20)31232-0. doi: 10.1016/j.cell.2020.
    >> Share

  108. MORENS DM, Fauci AS
    Emerging Pandemic Diseases: How We Got to COVID-19.
    Cell. 2020;182:1077-1092.
    >> Share

    August 2020
  109. GRUBAUGH ND, Hanage WP, Rasmussen AL
    Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear.
    Cell. 2020;182:794-795.
    >> Share

  110. KORBER B, Fischer WM, Gnanakaran S, Yoon H, et al
    Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
    Cell. 2020;182:812-827.
    >> Share

  111. KREER C, Zehner M, Weber T, Ercanoglu MS, et al
    Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.
    Cell. 2020;182:843-854.
    >> Share

  112. BARNES CO, West AP Jr, Huey-Tubman KE, Hoffmann MAG, et al
    Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies.
    Cell. 2020;182:828-842.
    >> Share

  113. GEITMANN A
    Travel Less. Make It Worthwhile.
    Cell. 2020;182:790-793.
    >> Share

  114. WANG H, Zhang Y, Huang B, Deng W, et al
    Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2.
    Cell. 2020;182:713-721.
    >> Share

  115. DAI L, Zheng T, Xu K, Han Y, et al
    A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS.
    Cell. 2020;182:722-733.
    >> Share

  116. BOUHADDOU M, Memon D, Meyer B, White KM, et al
    The Global Phosphorylation Landscape of SARS-CoV-2 Infection.
    Cell. 2020;182:685-712.
    >> Share

  117. SUN J, Zhuang Z, Zheng J, Li K, et al
    Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment.
    Cell. 2020;182:734-743.
    >> Share

  118. HASSAN AO, Case JB, Winkler ES, Thackray LB, et al
    A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies.
    Cell. 2020;182:744-753.
    >> Share

    July 2020
  119. EINAV T, Gentles LE, Bloom JD
    SnapShot: Influenza by the Numbers.
    Cell. 2020;182:532-532.
    >> Share

  120. JIANG RD, Liu MQ, Chen Y, Shan C, et al
    Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2.
    Cell. 2020;182:50-58.
    >> Share

  121. SHEN B, Yi X, Sun Y, Bi X, et al
    Proteomic and Metabolomic Characterization of COVID-19 Patient Sera.
    Cell. 2020;182:59-72.
    >> Share

  122. CAO Y, Su B, Guo X, Sun W, et al
    Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells.
    Cell. 2020;182:73-84.
    >> Share

  123. JOYCE MG, Wheatley AK, Modjarrad K
    Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks.
    Cell. 2020;182:7-9.
    >> Share

    June 2020
  124. SEMPOWSKI GD, Saunders KO, Acharya P, Wiehe KJ, et al
    Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19.
    Cell. 2020;181:1458-1463.
    >> Share

  125. BOST P, Giladi A, Liu Y, Bendjelal Y, et al
    Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients.
    Cell. 2020;181:1475-1488.
    >> Share

  126. GRIFONI A, Weiskopf D, Ramirez SI, Mateus J, et al
    Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.
    Cell. 2020;181:1489-1501.
    >> Share

  127. ZEGGINI E, Baumann M, Gotz M, Herzig S, et al
    Biomedical Research Goes Viral: Dangers and Opportunities.
    Cell. 2020;181:1189-1193.
    >> Share

  128. ZHANG K, Liu X, Shen J, Li Z, et al
    Clinically Applicable AI System for Accurate Diagnosis, Quantitative Measurements, and Prognosis of COVID-19 Pneumonia Using Computed Tomography.
    Cell. 2020;181:1423-1433.
    >> Share

  129. CASANOVA JL, Su HC
    A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection.
    Cell. 2020;181:1194-1199.
    >> Share

    May 2020
  130. NETEA MG, Giamarellos-Bourboulis EJ, Dominguez-Andres J, Curtis N, et al
    Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection.
    Cell. 2020;181:969-977.
    >> Share

  131. BLANCO-MELO D, Nilsson-Payant BE, Liu WC, Uhl S, et al
    Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.
    Cell. 2020;181:1036-1045.
    >> Share

  132. ZIEGLER CGK, Allon SJ, Nyquist SK, Mbano IM, et al
    SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.
    Cell. 2020;181:1016-1035.
    >> Share

  133. FAUVER JR, Petrone ME, Hodcroft EB, Shioda K, et al
    Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States.
    Cell. 2020;181:990-996.
    >> Share

  134. WRAPP D, De Vlieger D, Corbett KS, Torres GM, et al
    Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies.
    Cell. 2020;181:1004-1015.
    >> Share

  135. LU J, du Plessis L, Liu Z, Hill V, et al
    Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China.
    Cell. 2020;181:997-1003.
    >> Share

  136. HOU YJ, Okuda K, Edwards CE, Martinez DR, et al
    SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.
    Cell. 2020 May 27. pii: S0092-8674(20)30675-9. doi: 10.1016/j.cell.2020.
    >> Share

  137. OBERFELD B, Achanta A, Carpenter K, Chen P, et al
    SnapShot: COVID-19.
    Cell. 2020;181:954-954.
    >> Share

  138. MONTEIL V, Kwon H, Prado P, Hagelkruys A, et al
    Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2.
    Cell. 2020;181:905-913.
    >> Share

    April 2020
  139. ABBOTT TR, Dhamdhere G, Liu Y, Lin X, et al
    Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza.
    Cell. 2020 Apr 29. pii: S0092-8674(20)30483-9. doi: 10.1016/j.cell.2020.
    >> Share

  140. WANDZIK JM, Kouba T, Karuppasamy M, Pflug A, et al
    A Structure-Based Model for the Complete Transcription Cycle of Influenza Polymerase.
    Cell. 2020 Apr 16. pii: S0092-8674(20)30389-5. doi: 10.1016/j.cell.2020.
    >> Share


  141. COVID-19: Navigating Uncertainties Together.
    Cell. 2020;181:209-210.
    >> Share

  142. ZHANG YZ, Holmes EC
    A Genomic Perspective on the Origin and Emergence of SARS-CoV-2.
    Cell. 2020;181:223-227.
    >> Share

  143. HOFFMANN M, Kleine-Weber H, Schroeder S, Kruger N, et al
    SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
    Cell. 2020;181:271-280.
    >> Share

    March 2020
  144. ZHANG T, Yin C, Boyd DF, Quarato G, et al
    Influenza Virus Z-RNAs Induce ZBP1-Mediated Necroptosis.
    Cell. 2020;180:1115-1129.
    >> Share


  145. The Novel Coronavirus Outbreak: What We Know and What We Don't.
    Cell. 2020;180:1034-1036.
    >> Share

    January 2020
  146. VAHEY MD, Fletcher DA
    Low-Fidelity Assembly of Influenza A Virus Promotes Escape from Host Cells.
    Cell. 2020;180:205.
    >> Share

    May 2019
  147. GARCIA-SASTRE A
    Snatch-and-Grab Inhibitors to Fight the Flu.
    Cell. 2019;177:1367.
    >> Share

  148. BANGARU S, Lang S, Schotsaert M, Vanderven HA, et al
    A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface.
    Cell. 2019;177:1136-1152.
    >> Share

  149. WATANABE A, McCarthy KR, Kuraoka M, Schmidt AG, et al
    Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism.
    Cell. 2019;177:1124-1135.
    >> Share

  150. WU Y, Gao GF
    "Breathing" Hemagglutinin Reveals Cryptic Epitopes for Universal Influenza Vaccine Design.
    Cell. 2019;177:1086-1088.
    >> Share

    January 2019
  151. VAHEY MD, Fletcher DA
    Low-Fidelity Assembly of Influenza A Virus Promotes Escape from Host Cells.
    Cell. 2019;176:678.
    >> Share

  152. MARTIN BE, Brooke CB
    Flu Shows the Power of Diversity.
    Cell. 2019;176.
    >> Share

    November 2018
  153. VAHEY MD, Fletcher DA
    Low-Fidelity Assembly of Influenza A Virus Promotes Escape from Host Cells.
    Cell. 2018 Nov 27. pii: S0092-8674(18)31455-7. doi: 10.1016/j.cell.2018.
    >> Share

    June 2018
  154. DAS DK, Govindan R, Nikic-Spiegel I, Krammer F, et al
    Direct Visualization of the Conformational Dynamics of Single Influenza Hemagglutinin Trimers.
    Cell. 2018 Jun 21. pii: S0092-8674(18)30713-X. doi: 10.1016/j.cell.2018.
    >> Share

    April 2018
  155. CHEN YQ, Wohlbold TJ, Zheng NY, Huang M, et al
    Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies.
    Cell. 2018;173:417-429.
    >> Share

    March 2018
  156. GAO GF
    From "A"IV to "Z"IKV: Attacks from Emerging and Re-emerging Pathogens.
    Cell. 2018;172:1157-1159.
    >> Share

    January 2018
  157. GAYA M, Barral P, Burbage M, Aggarwal S, et al
    Initiation of Antiviral B Cell Immunity Relies on Innate Signals from Spatially Positioned NKT Cells.
    Cell. 2018;172:517-533.
    >> Share

    May 2017
  158. RIALDI A, Hultquist J, Jimenez-Morales D, Peralta Z, et al
    The RNA Exosome Syncs IAV-RNAPII Transcription to Promote Viral Ribogenesis and Infectivity.
    Cell. 2017;169:679-692.
    >> Share

    September 2016
  159. WANG A, Huen SC, Luan HH, Yu S, et al
    Opposing Effects of Fasting Metabolism on Tissue Tolerance in Bacterial and Viral Inflammation.
    Cell. 2016;166:1512-1525.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016